AMSilk
AMSilk is a leading innovator in advanced biomaterials, specializing in silk-based proteins. Utilizing a patented technology platform, the company produces sustainable, biodegradable, and microplastic-free materials that can be transformed into various forms such as fibers, hydrogels, and coatings. These high-performance biomaterials are used across multiple industries, including textiles, automotive, and consumer care, offering significant benefits and new possibilities for product development. AMSilk collaborates with global industry leaders to drive the industrialization and commercialization of its pioneering biotech materials.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $52M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $52M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 09, 2025 | Series C | $52.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Novo Holdings | Series C |
| ATHOS | Series C |
| MIG Capital | Series C |
Similar Companies
A snapshot of private companies similar to AMSilk, helping you discover and navigate related company profiles.
Related News and Analysis
